Zeruesenay Desta

Indiana University School of Medicine

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

52h-index12.2kcitations265works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmacogenetics and Drug Metabolism(105), Estrogen and related hormone effects(87), HIV/AIDS drug development and treatment(45), Drug Transport and Resistance Mechanisms(30), Inflammatory mediators and NSAID effects(23)

Publications265 total

Genotype–Specific Safety and Pharmacokinetics of Cannabidiol in Healthy Volunteers
Clinical and Translational Science·2025Open Access
Cannabidiol exerts antiinflammatory effects but maintains T effector memory cell differentiation in humans
JCI Insight·2025Open Access
Cannabidiol Alters Circulating Lymphocytes Composition in a Concentration-Dependent Manner: A Single-Cell Study in Humans
Journal of the American Society of Nephrology·2025
2.49 Escitalopram-Related Activation in Adolescents: It’s Not Just the Dose, It’s the Target
Journal of the American Academy of Child & Adolescent Psychiatry·2025
A Population Pharmacokinetic Approach to Understand the Effect of Efavirenz on <scp>CYP3A</scp> Activity in Healthy Volunteers Using Midazolam as a Probe
CPT Pharmacometrics & Systems Pharmacology·2025· 1 citedOpen Access
Clinical Pharmacogenetics Implementation Consortium Guideline for <scp> <i>NAT2</i> </scp> Genotype and Hydralazine Therapy
Clinical Pharmacology & Therapeutics·2025· 1 citedOpen Access
Pharmacogenetics of steady-state metabolism, pharmacokinetics, and adverse effects of voriconazole in healthy participants
Drug Metabolism and Disposition·2025· 1 citedOpen Access
Cannabidiol exerts anti-inflammatory effects but maintains T effector memory cell differentiation: A Single-Cell Study in Humans
2025Open Access
Evaluating the Evidence for <scp>CYP2C19</scp> Inhibitor Classifications: A Scoping Review
Clinical Pharmacology & Therapeutics·2025· 3 cited
The strong clinical interaction between bupropion and CYP2D6 is primarily mediated through bupropion metabolites and their stereoisomers: A paradigm for evaluating metabolites in drug-drug interaction risk
Drug Metabolism and Disposition·2025· 1 cited
Inhibition of Tacrolimus Metabolism by Cannabidiol and Its Metabolites In Vitro
Clinical and Translational Science·2025· 3 citedOpen Access
A Phase I Trial of the Pharmacokinetic Interaction Between Cannabidiol and Tacrolimus
Clinical Pharmacology & Therapeutics·2024· 8 citedOpen Access
The steady-state pharmacokinetics of fixed-dose combination dolutegravir+rilpivirine in hemodialysis
AIDS·2024· 1 cited
2.34 Variability in Sertraline Pharmacokinetics Explained By CYP2C19 and CYP2B6
Journal of the American Academy of Child & Adolescent Psychiatry·2024Open Access
Data from Anastrozole Dose Escalation for Optimal Estrogen Suppression in Postmenopausal Early-Stage Breast Cancer: A Prospective Trial
2024· 1 citedOpen Access
Supplemental Table 2 from Anastrozole Dose Escalation for Optimal Estrogen Suppression in Postmenopausal Early-Stage Breast Cancer: A Prospective Trial
2024Open Access
Supplemental Table 1 from Anastrozole Dose Escalation for Optimal Estrogen Suppression in Postmenopausal Early-Stage Breast Cancer: A Prospective Trial
2024Open Access
Data from Anastrozole Dose Escalation for Optimal Estrogen Suppression in Postmenopausal Early-Stage Breast Cancer: A Prospective Trial
2024Open Access
Supplemental Table 1 from Anastrozole Dose Escalation for Optimal Estrogen Suppression in Postmenopausal Early-Stage Breast Cancer: A Prospective Trial
2024Open Access
Supplemental Table 3 from Anastrozole Dose Escalation for Optimal Estrogen Suppression in Postmenopausal Early-Stage Breast Cancer: A Prospective Trial
2024Open Access
page 1 of 14Next →

Frequent Co-authors

David A. Flockhart(38), Todd C. Skaar(11), James M. Rae(8), Anne Nguyen(7), Vered Stearns(6), Evan T. Ogburn(6), Richard M. Weinshilboum(5), Daniel F. Hayes(5), Bryan A. Ward(5), Nadia Soukhova(5), Anna Maria Storniolo(4), Teri E. Klein(4), Lang Li(4), Matthew P. Goetz(3), Edith A. Perez(3), James N. Ingle(3), Andrea Gaedigk(3), Rachel F. Tyndale(3), Taisei Mushiroda(3), Michiaki Kubo(3)